ALTRAPHARMA Invest ApS: Financial statements 2020
CVR: 34483884
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
ALTRAPHARMA Invest ApS (CVR 34483884) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 527,450 and a net result of DKK 407,135 compared with DKK 109,552 the year before. That is an increase of 233.8% compared with the year before. Equity in the 2020 report amounted to DKK 699,453. The solvency ratio was 72.8%.
- Gross Profit
- DKK 527,450
- Profit/Loss
- DKK 407,135
- Equity
- DKK 699,453
- Total Assets
- DKK 961,254
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 527 t. | 407 t. | 699 t. | 0 |
| 2019 | - | 158 t. | 110 t. | 292 t. | 0 |
| 2017 | - | 473 t. | 270 t. | 517 t. | 0 |
| 2016 | - | 1.2 mio. | 67 t. | 247 t. | 0 |
| 2015 | - | 843 t. | 7 t. | 379 t. | - |
Official annual report
How creditworthy is ALTRAPHARMA Invest ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout ALTRAPHARMA Invest ApS
ALTRAPHARMA Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named ALTRAPHARMA ApS. The management consists of Marianne Thrane. The company is owned by ALTRA 14 ApS and Juniwik Business Management AB. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -88,915 and a net result of DKK -84,944 compared with DKK 86,556 the year before. Equity in the 2025 report amounted to DKK 103,766.